PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 16th Aug 2013 08:52

African Minerals: Barclays initiates with a target price of 220p and an underweight rating.Aviva: Exane downgrades to neutral with a target price of 403p.Avon Rubber: Investec ups target price from 470p to 500p, but downgrades from add to hold.AZ Electronic Materials: Deutsche Bank reduces target price from 380p to 350p and retains a hold recommendation. Canaccord Genuity cuts target price from 414p to 389p, while its buy recommendation remains unaltered.Balfour Beatty: Liberum Capital increases target price from 190p to 250p and upgrades to buy.BHP Billiton: JP Morgan cuts target price from 2340p to 2310p and keeps a neutral rating.Cineworld Group: JP Morgan ups target price from 368p to 428p maintaining an overweight rating.Derwent London: Exane moves target price from 2300p to 2360p, while its neutral rating remains unchanged.Ferrexpo: Barclays initiates with a target price of 200p and an underweight rating.GemDiamonds: Goldman Sachs shifts target price from 175p to 180p and maintains a buy recommendation.GlaxoSmithKline: Bank of America raises target price from 1910p to 2050p and reiterates a buy recommendation.Gulf Keystone Petroleum: Goldman Sachs downgrades to neutral with its target price at 265p.Imperial Tabacco: Bank of America cuts target price from 2380p to 2300p, while keeping a neutral rating.London Mining: Barclays initiates with a target price of 110p and an underweight rating.Ophir Energy: Credit Suisse reduces target price from 604p to 550p retaining an outperform rating. Exane lowers target price from 570p to 540p and stays with its outperform rating. Canaccord Genuity cuts target price from 425p to 374p and reiterates a hold recommendation.Pearson: Morgan Stanley moves target price from 1215p to 1225p, while maintaining an underweight rating.Prudential: Nomura increases target price from 1392p to 1487p leaving its buy recommendation unchanged.Resolution: Oriel Securities raises target price from 285p to 340p keeping its hold recommendation.Royal Bank of Scotland: Investec downgrades from hold to sell with a target price of 340p.Talvivaara Mining: JP Morgan shifts target price from 13p to 12p and stays with its neutral rating.WPP Group: Liberum Capital takes target price from 1180p to 1300p and keeps its buy recommendation.
More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.